|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-9-5
|
|
pubmed:abstractText |
RCAS1 is a novel tumor marker, and there are no sufficient data about the utility of this antigen as a serum tumor marker and about its tumor specificity. We aimed at measuring the serum levels of RCAS1 in patients with pancreatic cancer and at determining its diagnostic efficacy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1424-3903
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2006 S. Karger AG, Basel and IAP.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
268-72
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16636598-Adenocarcinoma,
pubmed-meshheading:16636598-Adult,
pubmed-meshheading:16636598-Aged,
pubmed-meshheading:16636598-Aged, 80 and over,
pubmed-meshheading:16636598-Antigens, Neoplasm,
pubmed-meshheading:16636598-Biliary Tract Diseases,
pubmed-meshheading:16636598-CA-19-9 Antigen,
pubmed-meshheading:16636598-Diagnosis, Differential,
pubmed-meshheading:16636598-Female,
pubmed-meshheading:16636598-Humans,
pubmed-meshheading:16636598-Male,
pubmed-meshheading:16636598-Middle Aged,
pubmed-meshheading:16636598-Pancreatic Diseases,
pubmed-meshheading:16636598-Pancreatic Neoplasms,
pubmed-meshheading:16636598-Prognosis,
pubmed-meshheading:16636598-Tumor Markers, Biological
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases.
|
|
pubmed:affiliation |
Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
